Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofCeftriaxone and Tazobactam for Injectionfrom Surat, Gujarat, India. Ceftriaxone And Tazobactam for Injection used for the treatment of a number of bacterial infections.
Tags: Ceftriaxone and Tazobactam for Injection manufacturer, Ceftriaxone AndTazobactam for Injection exporter, Ceftriaxone and Tazobactam for Injection Supplier, and Ceftriaxone and Tazobactam for Injection, whogmp approved Ceftriaxone AndTazobactam for Injection manufacturer and supplier, Ceftriaxone and Tazobactamfor Injection distributor, Ceftriaxone and Tazobactam for Injection shipper,Ceftriaxone and Tazobactam for Injection3.375 mgCeftriaxone and Tazobactam forInjection 3.375 mg supplier, Ceftriaxone and Tazobactamfor Injection3.375 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy LifescienceCeftriaxone and Tazobactamfor Injection export to USA, Canada, Germany, Europe, France, Ghana,Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru,Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia,Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.
SAINTROY LIFESCIENCE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |